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Diverticular disease is one of the most common diseases of the gastrointestinal (GI) tract 
requiring in-hospital treatment in Western countries. Despite its high incidence, controversies 
remain about the optimal treatment of the different stages of this disease.  
Most people with diverticular disease remain asymptomatic; however, approximately 15% 
develop symptoms, and of these, 15% will develop significant complications such as 
perforation [1]. Although the absolute prevalence of perforated diverticulitis (PD) 
complicated by generalized peritonitis is low, its importance lies in the significant 
postoperative mortality rate, ranging from 4–26% [2–4]. Owing to the low prevalence of 
generalized peritonitis due to PD (GPPD), strategies for the treatment of this stage of 
diverticulitis are even less thoroughly investigated. There are two major reasons for this.  
Firstly, in the pathogenesis of diverticular disease, diverticulitis and perforation seem to have 
multifactorial origins, including lifelong dietary habits, medicine use, coexistence of other 
bowel or collagen-related diseases, and genetic influences. This complex interaction of 
factors makes it very difficult to investigate. Nevertheless, fundamental epidemiological 
research is warranted to assess the etiology of this disease and subsequently to develop 
prevention strategies. 
Secondly, although uncomplicated diverticulitis is a common GI disease, the incidence of PD 
is relatively low (fewer than four cases per 100 000) [3]. Owing to this low incidence, it is 
difficult to design and successfully complete randomized controlled trials to assess optimal 
treatment strategies. Operations for PD are classified as emergency and may be performed 
outside office hours, rendering it even more difficult to start such trials.  
Nevertheless, the consequences of this disease for general healthcare and for the patients in 
particular are enormous, as it is accompanied by high morbidity and mortality rates and poor 
quality of life after having survived the event. Healthcare costs are significant owing to long 
periods of intensive care and overall hospital stay, the high rate of additional interventions or 
operations to treat complications, and outpatient stoma care.  
 
Etiology  
The prevalence of diverticulosis is estimated at 5% by the age of 40 years and up to 50–70% 
at 80 years of age [1,5]. Its exact prevalence is difficult to assess because most people remain 
asymptomatic [1]. Only about 15% of patients with diverticulosis will manifest any related 
clinical symptoms [1,6]. Approximately 80% of patients presenting with PD do not have a 
previous history of diverticular disease [7]. 
The pathogenesis of this disease process is probably multifactorial involving dietary habits 
(low fiber), changes in colonic pressure, motility, and wall structure associated with ageing, 
along with other factors [8]. The reason why a subgroup of individuals with diverticulosis 
progresses from asymptomatic to symptomatic or even to complicated PD remains poorly 
understood. 
Dietary shifts during the past century have likely not only influenced colonic motility and 
intraluminal pressure, but also altered colonic flora [9]. The change in the colonic microbial 
environment may be an important element in the transformation of asymptomatic diverticular 
disease into diverticulitis, but its exact role has not been adequately defined [10].  
Like the pathophysiology of diverticula, the etiology of diverticular inflammation is also 
speculative. The development of diverticulitis has been described as similar to that of 
appendicitis. Perforation of variable extent may result, accounting for a range of symptoms 
[11,12]. 
In general, patients with diverticular disease show raised intracolonic pressures, especially in 
the sigmoid colon [13]. As almost all diverticular perforations occur in the sigmoid colon, 
these pressure changes must be an important etiological factor. Furthermore, the properties of 
the colonic wall are likely important because diverticula consist predominantly of mucosa 
lacking a smooth muscle layer. The mucosal barrier is vulnerable and may be impaired by 
various exogenous factors, such as the use of nonsteroidal anti-inflammatory drugs 
(NSAIDs), corticosteroids or opiate analgesics, smoking, and alcohol consumption [14]. 
The etiology of perforation remains unknown, but it is thought to be a result of an excessive 
increase in intradiverticular pressure and focal necrosis [15]. This local perforation may form 
pericolic phlegmones and pus collections (Hinchey I) [16]. If this process progresses further, 
localized abscesses may form between loops of the small bowel or in the pelvic peritoneum 
(Hinchey II). If the pus cannot be contained, the abdominal peritoneum becomes 
contaminated, producing generalized purulent peritonitis (Hinchey III). The same is found 
when a large intraperitoneal diverticular abscess ruptures into the abdominal cavity [17]. If 
the initial perforation is large, fecal contamination of the abdominal cavity can occur 
(Hinchey IV) [16]. 
Since the incidence of diverticulosis increases with age, the majority of patients presenting 
with symptoms are elderly. Complicated diverticulitis is also observed predominantly in older 
patients. This problem is caused by an obscure presentation of diverticular complications in 
the elderly patient, with a consequent delay in diagnosis. Polypharmacy (e.g. with NSAIDs or 
corticosteroids) may further exacerbate this problem and may even increase the risk of 
developing complications [18]. 
 
Prevention   
The possible role of diet and lifestyle offers strategies for prevention. Large, prospective 
studies have identified a preventive effect of both vegetable and high fiber intake and 
physical exercise in the development of diverticular disease, as well as diverticulitis [19–21]. 
Fiber as a dietary supplement may be beneficial in prevention. Nevertheless, it is remarkable 
that the incidence of diverticular disease has not been reduced, given the fact that several 
studies have shown an increased intake of fiber in Western populations over the last three 
decades [22]. The exact role of fiber in the pathophysiology of diverticulosis and its 
prevention remains unclear. Furthermore, when symptoms have developed, evidence of a 
benefit of fiber intake is even less convincing [22].  
One of the latest therapies for the prevention of recurrent diverticulitis is the use of 
mesalazine, rifaximin, or a combination of the two [23,24]. The rationale for mesalazine use 
is that it inhibits some key factors of the inflammatory cascade [25]. Another very recent 
therapeutic strategy is the use of probiotics [26]. Probiotics diminish changes in the spectrum 
of intestinal microflora and the adherence and translocation of pathogens. They also regulate 
the production of antimicrobials and interact as competitive metabolites with pro-
inflammatory organisms. Importantly, the combination of the Lactobacillus spp. with 
rifaximin seems effective in reducing severe forms of diverticulitis and preventing 
recurrences, hence reducing surgical treatment significantly [27,28].  
The role of surgery in the prevention of complicated diverticular disease is unclear. Advances 
in diagnostic modalities, medical therapy, and surgical techniques over the past two decades 
have changed both the management and outcomes of diverticulitis [29]. Patients treated 
nonoperatively would be expected to do well without elective colectomy since most patients 
will not have further episodes of diverticulitis [30,31]. Recurrent episodes of diverticulitis do 
not lead to more complications or failure of conservative treatment [3,32]. At present, it is 
thought that elective resection for uncomplicated diverticulitis does not alter outcome, nor 
does it decrease mortality or prevent severe complications of the disease (e.g. perforation) 
[31,32]. Moreover, the prevalence of persistent symptoms after surgery for diverticular 
disease (up to 25%) may be an additional reason to discuss the indication for prophylactic 
surgery. 
 PD with localized peritonitis: treatment strategies [H1] 
The optimal treatment strategy for PD depends on the degree of peritonitis. The introduction 
of computed tomography (CT) has improved preoperative assessment of diverticular disease. 
The CT-based classification by Hansen–Stock is the primary classification system and 
accounts for asymptomatic diverticulosis as well as complicated diverticulitis in different 
stages, including perforation [34]. Nevertheless, the degree of peritonitis – and hence the 
severity of disease – in PD can be represented best by Hinchey’s classification (Figure 1). 
Hinchey I and II represent localized peritonitis with phlegmone or abscess near the affected 
sigmoid and abscess elsewhere, respectively. Even localized PD can present as acute 
abdominal pain, frequently resulting in emergency surgery when preoperative CT scan for 
diagnosis is not performed.  
The high specificity of CT has allowed this modality to become a surrogate for the 
perioperative assessment made by the Hinchey classification [35]. Furthermore, CT has 
become an important therapeutic aid. It is now recognized that patients with small, contained 
perforations, who are not systemically ill, can be treated initially with antibiotics alone or by 
CT-guided percutaneous drainage [35,36]. Although mechanical control of the source of 
infection remains important, several studies have found that abscesses up to 4 cm seem to 
respond better to antibiotics alone [36,37]. 
Therefore, in general, Hinchey I and II PD can be treated conservatively with fluids, 
analgesics, and antibiotics, with or without percutaneous drainage of abscesses. It must also 
be noted that in Hinchey I and II, small amounts of free air are shown on CT scan, but this 
does not imply surgical treatment per se. If conservative treatment fails, surgical intervention 
is indicated, in which resection with primary anastomosis (PA) is preferred above sigmoid 
colectomy with subsequent colostomy, also referred to as Hartmann’s procedure (HP). The 
performance of a diverting loop-ileostomy to “protect” the anastomosis should be considered, 
especially in patients with more comorbidity factors [38]. 
 
PD with generalized peritonitis: treatment strategies  
Hinchey III and IV (GPPD) are characterized by generalized purulent and fecal peritonitis, 
respectively. Both represent indications for emergency surgery. Since the beginning of the 
previous century, a three-stage operation strategy was common practice for the treatment of 
complicated diverticular disease. A preliminary transverse colostomy was advised with a 
period of delay before resection of 3–6 months [39,40]. The rationale for this strategy was 
that primary resection is too difficult in the acute stage of the disease. After several months, 
the second stage – resection of the involved bowel – could be performed to treat and prevent 
relapse of the disease. 
Since the 1960s, combinations of antibiotics were used for the treatment of Gram-negative 
bacteria and anaerobic bacteria, and these resulted in improved survival in septic patients 
[41]. Unfortunately, mortality rates in patients with GPPD remained high. It was thought that 
the basic cause of this high mortality was the remaining source of infection in the peritoneal 
cavity. Based on this “expert opinion evidence”, the conviction arose that the colonic 
perforation had to be removed immediately [42,43].  
A two-stage operation (e.g. HP) subsequently became the preferred surgical strategy in these 
patients [44]. The second stage was represented by the colostomy closure. This change in 
strategy was mainly based on the results of two reviews published in 1980 and 1984 by Greif 
et al. [45] and Krukowski and Matheson [46], respectively. Unfortunately, these reviews were 
not systematic, containing a wide range of different surgical techniques and covering more 
than 25 years during which substantial improvements in antibiotic and other perioperative 
supportive therapies had taken place. Furthermore, it is not known whether the patients were 
comparable for a number of essential variables, such as age, American Society of 
Anesthesiologists (ASA) classification, and Hinchey scores.  
Between 1993 and 2000, two randomized controlled trials assessing primary versus 
secondary resection were published [47,48]. These randomized controlled trials drew 
opposing conclusions. Kronborg [47] concluded that three-stage nonresectional surgery 
(suture and transverse colostomy) in PD was still superior to primary resection because of a 
lower postoperative mortality rate; however, mortality was not different in Hinchey IV 
patients who underwent primary resection or patients who were treated according the three-
staged surgical strategy. Unfortunately, the study was stopped early because of low 
recruitment (an average of four patients each year) and hence underpowered. A total of 62 
patients were included and operated by 27 different surgeons over a period of 14 years. 
Zeitoun et al. concluded that primary resection was superior to nonresectional surgery 
because of less postoperative peritonitis and fewer reoperations [48]. However, postoperative 
mortality after primary resection was higher compared with nonresectional surgery (24% vs. 
19%). Nontheless, HP became the advocated surgical strategy. 
Improvements in surgical and radiological intervention techniques and progress in the 
management of peritoneal sepsis has resulted in increasing interest in colonic resection with 
PA since the 1990s. Several systematic reviews have concluded PA to have a better clinical 
outcome than HP for patients with GPPD [21]. However, fear of anastomotic leakage often 
deters many surgeons from performing a one-stage procedure (e.g. PA) in GPPD, although it 
is becoming more widely accepted that anastomotic leakage does not seem to be related to 
the grade of contamination of the abdomen. 
Restoration of bowel continuity after HP is a technically challenging operation and is 
associated with significant morbidity and mortality [49]. These rates can be as high as 25% 
and 14%, respectively, after colostomy reversal in patients who have undergone HP for PD 
[2,4]. The performance of a diverting loop-ileostomy has been reported to decrease the rate of 
symptomatic anastomotic leakage in patients operated on for diverticular peritonitis. The risk 
of a permanent ileostomy is recognizably less than that of HP, with fewer complications 
[50,51].  
In 1996, a new nonresectional laparoscopic approach was described [52]. In patients with 
peritonitis without gross fecal contamination, laparoscopic peritoneal lavage, inspection of 
the colon, and the placement of abdominal drains appeared to diminish morbidity and 
improve outcome [52–54]. In a series of 100 patients with GPPD, Myers et al. showed 
excellent results after laparoscopic lavage and drainage of the peritoneal cavity, with 
morbidity and mortality rates <5% [54].  
In a second elective stage, definitive surgery can take place (e.g. laparoscopic resection and 
PA) [53,54], although subsequent elective resection is probably unnecessary [55,56]. 
Nevertheless, the number of studies are rather limited and mostly based on small groups of 
patients. Furthermore, the rates of additional radiological interventions and conversion to an 
open procedure are high [57]. Finally, for many hospitals, it will not be possible to have a 
surgical team with expertise in colorectal laparoscopic surgery present at all times. 
Some authors have expressed their concerns regarding laparoscopic nonresectional treatment 
of GPPD. They state that the decision to perform nonresectional surgery is influenced by the 
surgical access to the abdomen (i.e. laparoscopy), rather than based on evidence in literature 
[58]. Unfortunately, the evidence to which these investigators refer (primary resection 
favoring three-stage procedures ) is equivocal or contradictory, as stated above [46–48]. 
The major criticism of the nonresectional laparoscopic lavage technique is the continued 
presence of the perforated colon as a septic focus and the column of feces in the colon as 
potential ongoing sources of contamination. This was also the main criticism towards the 
three-stage procedure that was used to treat GPPD until the 1970s. However, GPPD is 
accompanied by ileus, hence it is not likely that the fecal column is propelled towards the 
perforation. Moreover, a patent communication between the colonic lumen and the peritoneal 
cavity usually cannot be found during laparoscopy because the site of the original perforation 
has become sealed by the inflammatory process and omentum, and seems efficient to control 
the source of contamination. In patients who are found to have fecal peritonitis or who fail to 
improve after lavage, acute resection should still be performed [57,59]. 
The suggestion that nonresectional surgery in combination with more advanced antibiotics 
has never been proven to be an inferior strategy, could explain the excellent results after 
laparoscopic lavage in combination with modern management of peritoneal sepsis with 
improved antibiotics and intensive care medicine.  
In the case of Hinchey III peritonitis, laparoscopic treatment by lavage and drainage without 
resection has shown such excellent results that this new approach cannot be ignored [53-
55,57]. The problem is that Hinchey’s classification represents the severity of disease during 
surgery. Preoperative CT scanning is essential to differentiate between Hinchey I, II, and 
generalized peritonitis (Hinchey III and IV), but exact differentiation between purulent of 
fecal peritonitis is not possible with today’s radiological modalities. It is therefore advised 
that all patients with GPPD on CT scan undergo diagnostic laparoscopy. In cases of purulent 
peritonitis, laparoscopic lavage and drainage can then be performed. Alternatively, 
resectional surgery can be considered, for which PA is preferred. In cases of fecal peritonitis, 
conversion to laparotomy is advised to perform sigmoid resection with PA (or HP), as 
laparoscopic lavage and drainage have shown not to be successful in Hinchey IV PD.  
The abovementioned statements still need to be confirmed in randomized controlled trials. 
Currently, a nationwide randomized trial (Ladies [Laparoscopic Peritoneal Lavage or 
Resection for Generalized Peritonitis for PD] trial) is running in The Netherlands under the 
auspices of the Dutch Diverticular Disease (3D) Collaborative Study Group [60]. While 
awaiting the results of randomized trials assessing laparoscopic lavage, the open approach 
(PA or HP) presently remains the standard procedure in patients with generalized (purulent of 
fecal) peritonitis from a free macroperforation in diverticulitis. 
 
Future strategies   
Currently, the only patients who require surgery (laparoscopically or open) are those who fail 
conservative treatment and those with generalized peritonitis who require emergency surgery 
[37,61]. It seems that a more minimally invasive surgical treatment could be a safe and 
feasible option in GPPD. To ensure good results, it is essential that these procedures are 
performed by dedicated colorectal surgeons who have laparoscopic lavage in their 
armamentarium of procedures. Minimally invasive nonresectional treatment of GPPD has the 
highest probability of success. [53] 
If nonresectional laparoscopic lavage and drainage to treat GPPD is found to be a safe and 
better alternative for resectional surgery in the future, why should this be different from 
nonresectional nonsurgical (e.g. CT-guided) percutaneous lavage and drainage? As yet, the 
literature does not report this treatment strategy. Is it possible that this will be the next step in 
the ever more conservative management of different stages in diverticular disease?  
Fluid resuscitation and modern antibiotic strategies will not be different from 
laparoscopically lavage procedures. In order to gain control of the septic focus using 
percutaneous techniques, it is important that large size catheters are used for adequate 
drainage of thick and viscous purulent contents [62]. The main problem is the inability for 
inspection of the abdominal cavity to localize the site and size of the perforation. Such a 
careful inspection of the abdominal cavity, to look for or exclude other causes of generalized 
purulent peritonitis, is not possible using today’s radiographic modalities. Furthermore, in 
cases of a large perforation causing fecal peritonitis, source control by percutaneous lavage 
and drainage is impossible; hence, surgical treatment will be necessary to achieve source 
control and restore premorbid anatomy and function. It is, therefore, not likely that 
percutaneous (nonsurgical) nonresectional lavage and drainage will play a prominent role in 
the treatment of GPPD in the near future, because it cannot yet meet to the principles of 
abdominal infection treatment. 
 
Proposal for a treatment strategy for PD   
Further basic and clinical investigations need to be performed in order to fill the several gaps 
in our knowledge of the pathophysiology of diverticulitis, as well as its treatment and 
prevention. For the same reason, there is a need for further good quality epidemiological 
research to identify risk factors in diverticular perforation. Whether new insights into the 
etiology will lead to new surgical strategies for prevention and treatment of PD remains to be 
seen. 
Abdominal CT scanning is essential in patients suspected of having PD, because only patients 
with generalized peritonitis (free fluid and large amount of peritoneal free air) need to 
undergo emergency surgery. Unfortunately, CT scans cannot presently differentiate between 
Hinchey III or IV PD. The differentiation between the two is essential because the treatment 
strategy is different. It is therefore advised that patients who have GPPD on CT scan will 
undergo diagnostic laparoscopy, followed by definitive surgery. Hinchey III patients should 
undergo laparoscopic lavage and drainage, while Hinchey IV patients need to undergo 
conversion towards laparotomy for resection of the affected colon segment. Future 
randomized controlled trials must assess whether laparoscopic lavage for Hinchey III, and PA 
with ileostomy for Hinchey IV, are indeed the preferred surgical strategies. In cases of 
Hinchey I and II, a conservative treatment is advocated. 
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Figure 1. The Hinchey Classification of perforated diverticulitis. 
 
Redrawn with permission from Jacobs DO. Clinical practice. Diverticulitis. N Engl J Med 
2007; 357: 2057-2066. Copyright © 2007 Massachusetts Medical Society. All rights 
reserved. 
 
